Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Ezetimibe 10 mg vs EZETROL 10 mg in healthy Thai volunteers under fasting conditions
TCTR20200310003Phase 1Not yet recruiting
- Sponsor
- Lupin Limited
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Lupin Limited. Planned start May 2020; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20200310003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200310003.